Embark Veterinary

formerly Embark

Embark Dog DNA Test | Most Accurate Breed Identification‎ | Highest Reviewed Online

Boston, United States · Founded 2015 · $91.1M raised

Employees
1–10
Founded
2015
Business Model
B2C
Total Funding
$91.1M
Last Round
$75.0M Series BJul 2021
Rounds
7

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 7 funding rounds and 11 investors for this company. The full record is or through the API.

About

Embark Veterinary was founded by scientists and canine geneticists in collaboration with the Cornell University College of Veterinary Medicine. The company provides dog DNA tests based on the Illumina CanineHD microarray, covering 400+ breeds with 99 percent breed ID accuracy, plus screening for 270+ genetic health risks. Embark also offers the world's first canine Relative Finder, which uses patented technology to identify a dog's relatives based on shared DNA. Its mission is to end preventable disease in dogs by partnering with breed clubs, shelters, researchers, and veterinarians to uncover genetic causes of canine health conditions.

Summary

Embark Veterinary is a Genomics company based in Boston, United States, founded in 2015. It has raised $91.1M in total across 7 rounds, most recently a $75.0M Series B round in Jul 2021. Investors include Slow Ventures, F-Prime Capital and Founder Collective.

Tech & App Stack

10 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BJul 2021
$75.0M

Sign up to see all 7 events

Funding: Seed through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

GRAILIPO

Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...

Menlo Park, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$2.1BJun 2026
Ultima Genomics

Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...

Fremont, United States201–500Artificial Intelligence, Healthcare
Series ETotal funding$1.1BJun 2022
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Embark Veterinary on Indexed.vc
<a href="https://indexed.vc/companies/embark-veterinary"><img src="https://indexed.vc/api/badge/company/embark-veterinary" alt="Embark Veterinary on Indexed.vc" width="260" height="76" /></a>